Dose-dependent change in biomarkers during neoadjuvant endocrine therapy with fulvestrant: results from NEWEST, a randomized Phase II study

201296 citationsJournal Article

Authors

Good health and well-being

Published in: Breast Cancer Research and Treatment

Volume 133, Issue 1, pp. 237-246

Field-Weighted Citation Impact: 4.34